Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Piming Zhao"'
Autor:
Piming Zhao, Gizachew B. Tassew, Joanna Y. Lee, Babak Oskouian, Denise P. Muñoz, Jeffrey B. Hodgin, Gordon L. Watson, Felicia Tang, Jen-Yeu Wang, Jinghui Luo, Yingbao Yang, Sarah King, Ronald M. Krauss, Nancy Keller, Julie D. Saba
Publikováno v:
JCI Insight, Vol 6, Iss 8 (2021)
Sphingosine-1-phosphate lyase insufficiency syndrome (SPLIS) is a rare metabolic disorder caused by inactivating mutations in sphingosine-1-phosphate lyase 1 (SGPL1), which is required for the final step of sphingolipid metabolism. SPLIS features inc
Externí odkaz:
https://doaj.org/article/9c9d0a0bbea44c69ba3c08fe8f691e88
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e92749 (2014)
Anoctamin 6 (Ano6) belongs to a conserved gene family (TMEM16) predicted to code for eight transmembrane proteins with putative Ca2+-activated chloride channel (CaCC) activity. Recent work revealed that disruption of ANO6 leads to a blood coagulation
Externí odkaz:
https://doaj.org/article/566b06220be742f0b793e00a6ec6526a
Cardiac myosin binding protein-C plays no regulatory role in skeletal muscle structure and function.
Autor:
Brian Lin, Suresh Govindan, Kyounghwan Lee, Piming Zhao, Renzhi Han, K Elisabeth Runte, Roger Craig, Bradley M Palmer, Sakthivel Sadayappan
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e69671 (2013)
Myosin binding protein-C (MyBP-C) exists in three major isoforms: slow skeletal, fast skeletal, and cardiac. While cardiac MyBP-C (cMyBP-C) expression is restricted to the heart in the adult, it is transiently expressed in neonatal stages of some ske
Externí odkaz:
https://doaj.org/article/4d1264bd714f4b1d9f939002124a1319
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 2, Iss C (2013)
Myostatin (MSTN) is a negative regulator of skeletal muscle mass. Strategies to block myostatin signaling pathway have been extensively pursued to increase muscle mass in various disease settings including muscular dystrophy. Here, we report a new cl
Externí odkaz:
https://doaj.org/article/e18a4292b694489d8f024574dfca076a
Autor:
Anabel S. De la Garza-Rodea, Steven A. Moore, Jesus Zamora-Pineda, Eric P. Hoffman, Karishma Mistry, Ashok Kumar, Jonathan B. Strober, Piming Zhao, Jung H. Suh, Julie D. Saba
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 14; Pages: 7579
International journal of molecular sciences, vol 23, iss 14
International journal of molecular sciences, vol 23, iss 14
Duchenne muscular dystrophy (DMD) is a congenital myopathy caused by mutations in the dystrophin gene. DMD pathology is marked by myositis, muscle fiber degeneration, and eventual muscle replacement by fibrosis and adipose tissue. Satellite cells (SC
Autor:
Jen-Yeu Wang, Nancy Keller, Felicia Tang, Babak Oskouian, Denise P. Muñoz, Yingbao Yang, Jeffrey B. Hodgin, Joanna Y. Lee, Gizachew B. Tassew, Sarah M. King, Ronald M. Krauss, Julie D. Saba, Jinghui Luo, Piming Zhao, Gordon L. Watson
Publikováno v:
JCI insight, vol 6, iss 8
JCI Insight
JCI Insight, Vol 6, Iss 8 (2021)
JCI Insight
JCI Insight, Vol 6, Iss 8 (2021)
Sphingosine-1-phosphate lyase insufficiency syndrome (SPLIS) is a rare metabolic disorder caused by inactivating mutations in sphingosine-1-phosphate lyase 1 (SGPL1), which is required for the final step of sphingolipid metabolism. SPLIS features inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69c89f92b96328876aa030c5d6dc0e3e
https://escholarship.org/uc/item/9417592z
https://escholarship.org/uc/item/9417592z
Autor:
Suha Salim, Peter I. Benke, Friedhelm Hildebrandt, Khalid Alhasan, Stacey Kiat Hong Tay, Abdullah A. Alangari, Isaac Desheng Liu, Federico Torta, Nicole Weaver, Bonnie Sullivan, Karin Chen, Piming Zhao, Megan A. Cooper, Emily Tang, Alwin Loh, Markus R. Wenk, Jeffrey B. Hodgin, James A. Endrizzi, Weixing Ou, Jeremy Selva, Julie D. Saba, Olivia West, Austin Larson, Evren Gumus, Hui Kim Yap, Martin Zenker, Denise Li Meng Goh
Publikováno v:
J Inherit Metab Dis
Sphingosine-1-phosphate (S1P) lyase is a vitamin B6-dependent enzyme that degrades sphingosine-1-phosphate in the final step of sphingolipid metabolism. In 2017, a new inherited disorder was described caused by mutations in SGPL1, which encodes sphin
Autor:
Meng Zhang, Andrzej Witkowski, Joanna Y. Lee, Lucy A. Paul, Jennifer A. Beckstead, Julie D. Saba, Ana E. Aguilar, Latika Puri, Robert O. Ryan, Piming Zhao, Jung H. Suh
Publikováno v:
Investigational New Drugs. 36:743-754
Neuroblastoma is a childhood malignancy that accounts for approximately 15% of childhood cancer deaths. Only 20-35% of children with metastatic neuroblastoma survive with standard therapy. Identification of more effective therapies is essential to im
Autor:
Jennifer A. Beckstead, Lucy A. Paul, Latika Puri, Meng Zhang, Robert O. Ryan, Piming Zhao, Jung H. Suh, Julie D. Saba, Andrzej Witkowski, Joanna Y. Lee, Ana E. Aguilar
Publikováno v:
Investigational New Drugs. 37:1309-1309
The authors would like to note an omission of disclosure in this paper. Author JDS is cofounder, equity-holder, and consultant of GILTRx Therapeutics.
Publikováno v:
Journal of Biomedicine & Biotechnology. 2011, p1-9. 9p.